Hepatic fibrosis assessed using transient elastography independently associated with coronary artery calcification

Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: The Coronary Artery Risk Development in Young Adults Study

(2014) Lisa B. VanWagner et al.   ATHEROSCLEROSIS

Prevalence and extent of atherosclerotic coronary artery disease and related outcome based on coronary computed tomographic angiography in asymptomatic elderly patients: retrospective cohort study

(2014) Hye-Jeong Lee et al.   INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING

High prevalence of non-alcoholic fatty liver disease in the Chinese - results from the Hong Kong liver health census

(2014) James Fung et al.   LIVER INTERNATIONAL

Factors Affecting the Accuracy of Controlled Attenuation Parameter (CAP) in Assessing Hepatic Steatosis in Patients with Chronic Liver Disease

(2014) Kyu Sik Jung et al.   PLoS One

Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients

(2013) Mazen Noureddin et al.   HEPATOLOGY

Prevalence of nonalcoholic fatty liver disease in mainland of China: A meta-analysis of published studies

(2013) ZhanZhan Li et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population

(2013) Young Eun Chon et al.   LIVER INTERNATIONAL

NAFLD in Asia—as common and important as in the West

(2013) Geoffrey C. Farrell et al.   Nature Reviews Gastroenterology & Hepatology

Diastolic dysfunction is associated with an increased risk of contrast-induced nephropathy: a retrospective cohort study

(2013) Hyang Mo Koo et al.   BMC Nephrology

Nonalcoholic fatty liver disease is associated with coronary artery calcification

(2012) Donghee Kim et al.   HEPATOLOGY

Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States

(2012) Donghee Kim et al.   HEPATOLOGY

Nonalcoholic fatty liver disease in Asia: A story of growth

(2012) Vincent Wai-Sun Wong   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Increased risk of cardiovascular disease and chronic kidney disease in NAFLD

(2012) Enzo Bonora et al.   Nature Reviews Gastroenterology & Hepatology

The controlled attenuation parameter (CAP): A novel tool for the non-invasive evaluation of steatosis using Fibroscan®

(2011) M. Sasso et al.   Clinics and Research in Hepatology and Gastroenterology

Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis

(2010) Vasilios G Athyros et al.   LANCET

Association Between Nonalcoholic Fatty Liver Disease and Coronary Artery Calcification

(2009) Chien-Hua Chen et al.   DIGESTIVE DISEASES AND SCIENCES

Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study

(2009) Srinivasan Dasarathy et al.   JOURNAL OF HEPATOLOGY

The Global Impact of Hepatic Fibrosis and End-Stage Liver Disease

(2008) Young-Suk Lim et al.   Clinics in Liver Disease

Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?

(2008) G. Targher et al.   DIABETOLOGIA